ArticleBone marrow transplantation2023
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.
Abstract readPublished Erratum
In one paragraph
Article in Bone marrow transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
40 authors.
Alberto Mussetti *Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet De Llobregat, Barcelona, Spain. amussetti@iconcologia.net.
Leyre Bento *Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain.ORCID http://orcid.org/0000-0001-9929-8617
Mariana Bastos-Oreiro *Servicio de Hematología y Hemoterapia, Hospital Gral. Univ. Gregorio Marañón, Madrid, Madrid, Spain.
Blanca Rius-SansalvadorInstitut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet De Llobregat, Barcelona, Spain.ORCID http://orcid.org/0000-0001-9864-2906
Carmen AlboComplejo Hospitalario de Pontevedra, Pontevedra, Spain.
Rebeca BailenGregorio Marañón Health Research Institute, Madrid, Spain.
Pere BarbaDepartment of Hematology, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Ana BenzaquénHematology Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Valencia, Spain.
Javier BrionesDepartment of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain.
Ana Carolina CaballeroDepartment of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID http://orcid.org/0000-0002-4950-5259
António CamposServiço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto, Porto, Portugal.
Ignacio EspañolHematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Christelle FerraInstitut Català d´Oncologia-H. Germans Trias i Pujol, Badalona, Spain.ORCID http://orcid.org/0000-0003-4571-5125
Sebastián Garzón LópezHospital del SAS de Jerez, Jerez De La Frontera, Spain.
Pedro Antonio González SierraDepartment of Hematology, Complejo Hospitalario Universitario de Granada, Granada, Spain.ORCID http://orcid.org/0000-0002-6492-1728
Luisa Maria GuerraHematology Department, Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain.
Rafael HernaniHematology Department, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.ORCID http://orcid.org/0000-0003-1043-8076
Gloria IacoboniDepartment of Hematology, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, WA, Spain.
Ana Jiménez-UbietoCentro de Investigación Biomédica en Red Cáncer (CIBERONC), Hospital Universitario 12 de Octubre, Complutense University, CNIO, Madrid, MADRID, Spain.
Mi KwonDepartment of Hematology Institute of Health Research Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Lucía López CorralDepartment of Hematology, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain.
Oriana López-GodinoHematology Department, Hospital Universitario Morales Meseguer, Murcia, Spain.
Maria Carmen Martinez MunozHematopoietic Transplantation Unit and Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8401-7306
Nuria Martínez-CibriánHospital Clinic, Barcelona, Spain.
Juan Montoro GómezHematology Department, Hospital Universitario y Politécnico la Fe, Valencia, Spain.ORCID http://orcid.org/0000-0003-0024-8068
Laura Pérez-OrtegaHospital Universitario Virgen del Rocio, Sevilla, Spain.
Guillermo OrtíHU Vall d'Hebron, Barcelona, Spain.
Valentín Ortiz-MaldonadoDepartment of Hematology, Hospital Clinic de Barcelona, Barcelona, Spain.
Maria-Jesús PascualDepartment of Hematology, Hospital Regional Universitario de Málaga, Málaga, Spain.
María PereraHematology, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Spain.
Antonio PerezHematology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.ORCID http://orcid.org/0000-0002-6436-9195
Juan Luis RegueraHospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
Jose M SanchezDepartment of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Jaime SanzAvinguda Fernando Abril Martorell, Hospital Universitario La Fe, Valencia, Valencia, Spain.ORCID http://orcid.org/0000-0001-6934-4619
Anna TorrentHematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.
Lucrecia YáñezHematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Rosario VarelaHospital Universitario de A Coruna, A Coruna, Spain.ORCID http://orcid.org/0000-0002-2547-6668
Izaksun Ceberio EchechipiaHospital Universitario Donostia, San Sebastian, Spain.
Dolores CaballeroDepartment of Hematology, Hospital Universitario de Salamanca (HUS/IBSAL) and CIBERONC, Salamanca, Spain.
Anna SuredaDepartment of Clinical Hematology, Institut Català d'Oncologia - Hospital Duran I Reynals, IDIBELL, Barcelona, Spain.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
37076611What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.